Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Withdrawn × Ovarian Neoplasms × Dianhydrogalactitol × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Ovarian Neoplasms 1

Interventions

Carboplatin 9 Paclitaxel 7 olaparib 5 niraparib 5 Cyclophosphamide 4 Bevacizumab 4 Radiotherapy 3 Fulvestrant 3 veliparib 2 talazoparib 2 palbociclib 2 eribulin 2 dostarlimab 2 aldesleukin 2 Trastuzumab 2 Specimen Handling 2 Letrozole 2 Drug Therapy 2 Doxorubicin 2 Cisplatin 2 Capecitabine 2 Biopsy 2 Albumin-Bound Paclitaxel 2 tucotuzumab celmoleukin 1 trastuzumab duocarmazine 1 trastuzumab biosimilar HLX02 1 sotigalimab 1 sargramostim 1 rubitecan 1 romidepsin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03281681 2019-10-18

REPROVe

Kintara Therapeutics, Inc.

Phase 1/2 Withdrawn

Ovarian Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡